Global COPD Medication Market Growth (Status and Outlook) 2023-2029

February 2023 | 85 pages | ID: GEB51EBB6B5BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke.

LPI (LP Information)' newest research report, the “COPD Medication Industry Forecast” looks at past sales and reviews total world COPD Medication sales in 2022, providing a comprehensive analysis by region and market sector of projected COPD Medication sales for 2023 through 2029. With COPD Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COPD Medication industry.

This Insight Report provides a comprehensive analysis of the global COPD Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COPD Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global COPD Medication market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COPD Medication and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COPD Medication.

The global COPD Medication market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for COPD Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for COPD Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for COPD Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key COPD Medication players cover Roche, Novartis, GSK, Teva, AstraZeneca, Boehringer Ingelheim and Nephron Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of COPD Medication market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Short-Acting Bronchodilator
• Corticosteroids
• Methylxanthines
• Long-Acting Bronchodilators
• Combination Drugs

Segmentation by application

• Hospital
• Clinic
• Pharmacy
• Online Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Novartis
• GSK
• Teva
• AstraZeneca
• Boehringer Ingelheim
• Nephron Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COPD Medication Market Size 2018-2029
  2.1.2 COPD Medication Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 COPD Medication Segment by Type
  2.2.1 Short-Acting Bronchodilator
  2.2.2 Corticosteroids
  2.2.3 Methylxanthines
  2.2.4 Long-Acting Bronchodilators
  2.2.5 Combination Drugs
2.3 COPD Medication Market Size by Type
  2.3.1 COPD Medication Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global COPD Medication Market Size Market Share by Type (2018-2023)
2.4 COPD Medication Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Pharmacy
  2.4.4 Online Pharmacy
2.5 COPD Medication Market Size by Application
  2.5.1 COPD Medication Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global COPD Medication Market Size Market Share by Application (2018-2023)

3 COPD MEDICATION MARKET SIZE BY PLAYER

3.1 COPD Medication Market Size Market Share by Players
  3.1.1 Global COPD Medication Revenue by Players (2018-2023)
  3.1.2 Global COPD Medication Revenue Market Share by Players (2018-2023)
3.2 Global COPD Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COPD MEDICATION BY REGIONS

4.1 COPD Medication Market Size by Regions (2018-2023)
4.2 Americas COPD Medication Market Size Growth (2018-2023)
4.3 APAC COPD Medication Market Size Growth (2018-2023)
4.4 Europe COPD Medication Market Size Growth (2018-2023)
4.5 Middle East & Africa COPD Medication Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas COPD Medication Market Size by Country (2018-2023)
5.2 Americas COPD Medication Market Size by Type (2018-2023)
5.3 Americas COPD Medication Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC COPD Medication Market Size by Region (2018-2023)
6.2 APAC COPD Medication Market Size by Type (2018-2023)
6.3 APAC COPD Medication Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe COPD Medication by Country (2018-2023)
7.2 Europe COPD Medication Market Size by Type (2018-2023)
7.3 Europe COPD Medication Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa COPD Medication by Region (2018-2023)
8.2 Middle East & Africa COPD Medication Market Size by Type (2018-2023)
8.3 Middle East & Africa COPD Medication Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COPD MEDICATION MARKET FORECAST

10.1 Global COPD Medication Forecast by Regions (2024-2029)
  10.1.1 Global COPD Medication Forecast by Regions (2024-2029)
  10.1.2 Americas COPD Medication Forecast
  10.1.3 APAC COPD Medication Forecast
  10.1.4 Europe COPD Medication Forecast
  10.1.5 Middle East & Africa COPD Medication Forecast
10.2 Americas COPD Medication Forecast by Country (2024-2029)
  10.2.1 United States COPD Medication Market Forecast
  10.2.2 Canada COPD Medication Market Forecast
  10.2.3 Mexico COPD Medication Market Forecast
  10.2.4 Brazil COPD Medication Market Forecast
10.3 APAC COPD Medication Forecast by Region (2024-2029)
  10.3.1 China COPD Medication Market Forecast
  10.3.2 Japan COPD Medication Market Forecast
  10.3.3 Korea COPD Medication Market Forecast
  10.3.4 Southeast Asia COPD Medication Market Forecast
  10.3.5 India COPD Medication Market Forecast
  10.3.6 Australia COPD Medication Market Forecast
10.4 Europe COPD Medication Forecast by Country (2024-2029)
  10.4.1 Germany COPD Medication Market Forecast
  10.4.2 France COPD Medication Market Forecast
  10.4.3 UK COPD Medication Market Forecast
  10.4.4 Italy COPD Medication Market Forecast
  10.4.5 Russia COPD Medication Market Forecast
10.5 Middle East & Africa COPD Medication Forecast by Region (2024-2029)
  10.5.1 Egypt COPD Medication Market Forecast
  10.5.2 South Africa COPD Medication Market Forecast
  10.5.3 Israel COPD Medication Market Forecast
  10.5.4 Turkey COPD Medication Market Forecast
  10.5.5 GCC Countries COPD Medication Market Forecast
10.6 Global COPD Medication Forecast by Type (2024-2029)
10.7 Global COPD Medication Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche COPD Medication Product Offered
  11.1.3 Roche COPD Medication Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis COPD Medication Product Offered
  11.2.3 Novartis COPD Medication Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 GSK
  11.3.1 GSK Company Information
  11.3.2 GSK COPD Medication Product Offered
  11.3.3 GSK COPD Medication Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 GSK Main Business Overview
  11.3.5 GSK Latest Developments
11.4 Teva
  11.4.1 Teva Company Information
  11.4.2 Teva COPD Medication Product Offered
  11.4.3 Teva COPD Medication Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Teva Main Business Overview
  11.4.5 Teva Latest Developments
11.5 AstraZeneca
  11.5.1 AstraZeneca Company Information
  11.5.2 AstraZeneca COPD Medication Product Offered
  11.5.3 AstraZeneca COPD Medication Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 AstraZeneca Main Business Overview
  11.5.5 AstraZeneca Latest Developments
11.6 Boehringer Ingelheim
  11.6.1 Boehringer Ingelheim Company Information
  11.6.2 Boehringer Ingelheim COPD Medication Product Offered
  11.6.3 Boehringer Ingelheim COPD Medication Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Boehringer Ingelheim Main Business Overview
  11.6.5 Boehringer Ingelheim Latest Developments
11.7 Nephron Pharmaceuticals
  11.7.1 Nephron Pharmaceuticals Company Information
  11.7.2 Nephron Pharmaceuticals COPD Medication Product Offered
  11.7.3 Nephron Pharmaceuticals COPD Medication Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Nephron Pharmaceuticals Main Business Overview
  11.7.5 Nephron Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. COPD Medication Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Short-Acting Bronchodilator
Table 3. Major Players of Corticosteroids
Table 4. Major Players of Methylxanthines
Table 5. Major Players of Long-Acting Bronchodilators
Table 6. Major Players of Combination Drugs
Table 7. COPD Medication Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global COPD Medication Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global COPD Medication Market Size Market Share by Type (2018-2023)
Table 10. COPD Medication Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global COPD Medication Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global COPD Medication Market Size Market Share by Application (2018-2023)
Table 13. Global COPD Medication Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global COPD Medication Revenue Market Share by Player (2018-2023)
Table 15. COPD Medication Key Players Head office and Products Offered
Table 16. COPD Medication Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global COPD Medication Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global COPD Medication Market Size Market Share by Regions (2018-2023)
Table 21. Global COPD Medication Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global COPD Medication Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas COPD Medication Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas COPD Medication Market Size Market Share by Country (2018-2023)
Table 25. Americas COPD Medication Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas COPD Medication Market Size Market Share by Type (2018-2023)
Table 27. Americas COPD Medication Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas COPD Medication Market Size Market Share by Application (2018-2023)
Table 29. APAC COPD Medication Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC COPD Medication Market Size Market Share by Region (2018-2023)
Table 31. APAC COPD Medication Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC COPD Medication Market Size Market Share by Type (2018-2023)
Table 33. APAC COPD Medication Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC COPD Medication Market Size Market Share by Application (2018-2023)
Table 35. Europe COPD Medication Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe COPD Medication Market Size Market Share by Country (2018-2023)
Table 37. Europe COPD Medication Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe COPD Medication Market Size Market Share by Type (2018-2023)
Table 39. Europe COPD Medication Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe COPD Medication Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa COPD Medication Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa COPD Medication Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa COPD Medication Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa COPD Medication Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa COPD Medication Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa COPD Medication Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of COPD Medication
Table 48. Key Market Challenges & Risks of COPD Medication
Table 49. Key Industry Trends of COPD Medication
Table 50. Global COPD Medication Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global COPD Medication Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global COPD Medication Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global COPD Medication Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Roche Details, Company Type, COPD Medication Area Served and Its Competitors
Table 55. Roche COPD Medication Product Offered
Table 56. Roche COPD Medication Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Novartis Details, Company Type, COPD Medication Area Served and Its Competitors
Table 60. Novartis COPD Medication Product Offered
Table 61. Novartis Main Business
Table 62. Novartis COPD Medication Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Novartis Latest Developments
Table 64. GSK Details, Company Type, COPD Medication Area Served and Its Competitors
Table 65. GSK COPD Medication Product Offered
Table 66. GSK Main Business
Table 67. GSK COPD Medication Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. GSK Latest Developments
Table 69. Teva Details, Company Type, COPD Medication Area Served and Its Competitors
Table 70. Teva COPD Medication Product Offered
Table 71. Teva Main Business
Table 72. Teva COPD Medication Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Teva Latest Developments
Table 74. AstraZeneca Details, Company Type, COPD Medication Area Served and Its Competitors
Table 75. AstraZeneca COPD Medication Product Offered
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca COPD Medication Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. AstraZeneca Latest Developments
Table 79. Boehringer Ingelheim Details, Company Type, COPD Medication Area Served and Its Competitors
Table 80. Boehringer Ingelheim COPD Medication Product Offered
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim COPD Medication Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim Latest Developments
Table 84. Nephron Pharmaceuticals Details, Company Type, COPD Medication Area Served and Its Competitors
Table 85. Nephron Pharmaceuticals COPD Medication Product Offered
Table 86. Nephron Pharmaceuticals Main Business
Table 87. Nephron Pharmaceuticals COPD Medication Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Nephron Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. COPD Medication Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global COPD Medication Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. COPD Medication Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. COPD Medication Sales Market Share by Country/Region (2022)
Figure 8. COPD Medication Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global COPD Medication Market Size Market Share by Type in 2022
Figure 10. COPD Medication in Hospital
Figure 11. Global COPD Medication Market: Hospital (2018-2023) & ($ Millions)
Figure 12. COPD Medication in Clinic
Figure 13. Global COPD Medication Market: Clinic (2018-2023) & ($ Millions)
Figure 14. COPD Medication in Pharmacy
Figure 15. Global COPD Medication Market: Pharmacy (2018-2023) & ($ Millions)
Figure 16. COPD Medication in Online Pharmacy
Figure 17. Global COPD Medication Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 18. Global COPD Medication Market Size Market Share by Application in 2022
Figure 19. Global COPD Medication Revenue Market Share by Player in 2022
Figure 20. Global COPD Medication Market Size Market Share by Regions (2018-2023)
Figure 21. Americas COPD Medication Market Size 2018-2023 ($ Millions)
Figure 22. APAC COPD Medication Market Size 2018-2023 ($ Millions)
Figure 23. Europe COPD Medication Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa COPD Medication Market Size 2018-2023 ($ Millions)
Figure 25. Americas COPD Medication Value Market Share by Country in 2022
Figure 26. United States COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC COPD Medication Market Size Market Share by Region in 2022
Figure 31. APAC COPD Medication Market Size Market Share by Type in 2022
Figure 32. APAC COPD Medication Market Size Market Share by Application in 2022
Figure 33. China COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 37. India COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe COPD Medication Market Size Market Share by Country in 2022
Figure 40. Europe COPD Medication Market Size Market Share by Type (2018-2023)
Figure 41. Europe COPD Medication Market Size Market Share by Application (2018-2023)
Figure 42. Germany COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 43. France COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa COPD Medication Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa COPD Medication Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa COPD Medication Market Size Market Share by Application (2018-2023)
Figure 50. Egypt COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country COPD Medication Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas COPD Medication Market Size 2024-2029 ($ Millions)
Figure 56. APAC COPD Medication Market Size 2024-2029 ($ Millions)
Figure 57. Europe COPD Medication Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa COPD Medication Market Size 2024-2029 ($ Millions)
Figure 59. United States COPD Medication Market Size 2024-2029 ($ Millions)
Figure 60. Canada COPD Medication Market Size 2024-2029 ($ Millions)
Figure 61. Mexico COPD Medication Market Size 2024-2029 ($ Millions)
Figure 62. Brazil COPD Medication Market Size 2024-2029 ($ Millions)
Figure 63. China COPD Medication Market Size 2024-2029 ($ Millions)
Figure 64. Japan COPD Medication Market Size 2024-2029 ($ Millions)
Figure 65. Korea COPD Medication Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia COPD Medication Market Size 2024-2029 ($ Millions)
Figure 67. India COPD Medication Market Size 2024-2029 ($ Millions)
Figure 68. Australia COPD Medication Market Size 2024-2029 ($ Millions)
Figure 69. Germany COPD Medication Market Size 2024-2029 ($ Millions)
Figure 70. France COPD Medication Market Size 2024-2029 ($ Millions)
Figure 71. UK COPD Medication Market Size 2024-2029 ($ Millions)
Figure 72. Italy COPD Medication Market Size 2024-2029 ($ Millions)
Figure 73. Russia COPD Medication Market Size 2024-2029 ($ Millions)
Figure 74. Spain COPD Medication Market Size 2024-2029 ($ Millions)
Figure 75. Egypt COPD Medication Market Size 2024-2029 ($ Millions)
Figure 76. South Africa COPD Medication Market Size 2024-2029 ($ Millions)
Figure 77. Israel COPD Medication Market Size 2024-2029 ($ Millions)
Figure 78. Turkey COPD Medication Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries COPD Medication Market Size 2024-2029 ($ Millions)
Figure 80. Global COPD Medication Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global COPD Medication Market Size Market Share Forecast by Application (2024-2029)